Literature DB >> 23631373

Lipoprotein subclass profiles in young adults born preterm at very low birth weight.

Petteri Hovi1, Eero Kajantie, Pasi Soininen, Antti J Kangas, Anna-Liisa Järvenpää, Sture Andersson, Johan G Eriksson, Mika Ala-Korpela, Karoliina Wehkalampi.   

Abstract

BACKGROUND: Adults born preterm at very low birth weight (VLBW ≤ 1500g) have increased risk factors for cardiovascular diseases including high blood pressure and impaired glucose regulation. Non-optimal lipoprotein profile is generally also likely to affect the increased cardiovascular risk, but lipoprotein subclass level data on adults born at VLBW are sparse. SUBJECTS AND METHODS: We studied 162 subjects born at VLBW and 169 term-born controls, aged 19 to 27 years. Total lipid, triglyceride and cholesterol concentrations of 14 lipoprotein subclasses were determined by proton nuclear magnetic resonance spectroscopy in the fasting state and in 2-hour serum samples from an oral glucose tolerance test.
FINDINGS: In comparison to controls, VLBW subjects had significantly higher fasting concentration of triglycerides in chylomicrons and largest very-low-density lipoprotein particles [XXL-VLDL-TG, difference 0.026 (95% CI: 0.004 to 0.049), P=0.024], and of triglycerides in small high-density lipoprotein particles [S-HDL-TG, 0.026 (95% CI: 0.002 to 0.051), P=0.037]. The seemingly important role of triglycerides was further supported by principal component analysis in which the first component was characterized by multiple lipoprotein triglyceride measures.
CONCLUSIONS: Young adults born at VLBW and their peers born at term had triglyceride-related differences in both VLDL and HDL subclasses. These differences suggest that the increased risk factors for cardiovascular diseases among the VLBW individuals in adulthood may partly relate to impaired triglyceride metabolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23631373      PMCID: PMC3661387          DOI: 10.1186/1476-511X-12-57

Source DB:  PubMed          Journal:  Lipids Health Dis        ISSN: 1476-511X            Impact factor:   3.876


Background

Adult-onset cardiovascular diseases have their origins partly in intrauterine and early postnatal life [1]. As young adults, very low birth weight (VLBW, ≤1500 g) infants have increased risk factors for cardiovascular diseases and type 2 diabetes [2-6]. They have, e.g., higher blood pressure than their term-born peers, and higher indexes of insulin resistance and glucose intolerance [2-6]. Some, although not all, studies have shown associations between preterm birth and a higher fat percentage in adulthood [5,7]. Findings on serum lipid profile are inconsistent. Although some studies have indicated that low gestational age at birth relates to non-optimal serum lipids in later life [8-10], most have not reported dyslipidemia in adults born preterm [2,5,7,11-13]. However, these studies have been limited to concentrations of lipids conventionally measured in clinical practice - total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol and total triglycerides, whereas lipoprotein subclasses may provide a more precise indicator for atherogenicity [14,15]. Here we investigated lipoprotein metabolism at subclass level in VLBW and control subjects from the Helsinki Study of Very Low Birth Weight Adults by proton nuclear magnetic resonance (NMR) spectroscopy.

Subjects and methods

The participants are from a longitudinal follow-up cohort of subjects born preterm at VLBW between 1978 and 1985 and discharged alive form the neonatal intensive care unit of Children's Hospital, Helsinki University Central Hospital, Finland. Of the original 335 survivors, 255 VLBW subjects lived in the greater Helsinki area at the time of follow-up and were invited to a clinical study together with a sex-, age-, and birth hospital-matched comparison group of 314 term-born subjects who were not small for gestational age (birth weight more than −2 SD) [16]; 166 VLBW and 172 controls participated. Of these, 4 and 3, respectively, were excluded because of not having fasted overnight, or being pregnant. Thus, the study finally included 162 VLBW and 169 term-born control subjects. None of these were treated with lipid lowering medication. One subject had type 1 diabetes. All subjects underwent a 75 g 2-hour oral glucose tolerance test (OGTT), based on which none had type 2 diabetes [5]. After an overnight fast of at least 8 hours, the clinical examination included weight and height measurement, and a 2-hour 75 g OGTT [5]. From both baseline- and 2-hour-sample, blood was drawn for lipoprotein subclass analysis. Moreover, the participants completed questionnaires that covered their medical history, smoking habits, and educational level of their parents. Total lipid (L), triglyceride (TG) and cholesterol (C) concentrations of 14 lipoprotein subclasses were analyzed by proton NMR spectroscopy in serum samples. The details of this methodology have been described [17,18] and this platform has recently been applied in large-scale epidemiological and genetic studies [19,20]. The lipoprotein subclass data are as follows: chylomicrons and largest (XXL) very-low-density lipoprotein (VLDL) particles (average particle diameter at least 75 nm); five different VLDL subclasses: very large (XL) VLDL (average particle diameter of 64.0 nm), large (L) VLDL (53.6 nm), medium (M) VLDL (44.5 nm), small (S) VLDL (36.8 nm), and very small (XS) VLDL (31.3 nm); intermediate-density lipoprotein (IDL) (28.6 nm); three LDL subclasses: L-LDL (25.5 nm), M-LDL (23.0 nm), and S-LDL (18.7 nm); and four HDL subclasses: XL-HDL (14.3 nm), L-HDL (12.1 nm), M-HDL (10.9 nm), and S-HDL (8.7 nm). Due to resolution and concentration issues TG and C are not available for every subclass [20]. The mean size for VLDL, LDL, and HDL particles was calculated by weighting the corresponding subclass diameters with their particle concentrations. IDL particles were included in the LDL measure. Altogether 44 lipoprotein measures were used. Statistical analyses were conducted using SPSS 17 and 19 software (IBM SPSS, Chicago, IL). Comparison of basic characteristics between VLBW and term was performed using t-test for continuous and chi-square -test for categorical variables. Because of skewed distributions lipoprotein subclass measurements were transformed as follows: 0.1 was added to avoid zero-values and natural logarithm was used to achieve more symmetrical distributions. Distributions were checked after logarithm transformation and those two that were not sufficiently normal were transformed again. To find a situation where the residuals of XXL-VLDL-TG and residuals of XXL-VLDL-L were fairly normal, we utilized the ‘Box-Cox transformations for linear models’ in the ‘car’-package downloaded in April 4th, 2013, to R-software, version 2.15.2. Oct 26, 2012. To avoid non-positive dependent values we added 0.1 to the dependent prior to the Box-Cox iterative procedure. The lambdas with maximal log likelihood were -7.3 and -5.3, for the respective outcomes, yielding to our best transformations for the full models: y’ = (y + 0.1)(/(lambda), where y = original variable. With these y’ as dependent in the full models, the resulting in symmetric distributions of residuals but, unfortunately, with less pronounced aggregation of mid values. We used multiple linear regression to compare individual lipoprotein subclass measurements between VLBW and control subjects. We adjusted for confounding factors in different models. The fully adjusted model included age, sex, height, highest parental education, body mass index, mother’s smoking during pregnancy, and daily smoking of the participant (yes/no) as covariates. Additionally we also adjusted for alcohol use in the fully adjusted model; dicotomized values for whether the subject used alcohol weekly to get drunk or not, and whether the subject ever used alcohol or not. We also adjusted for fasting and 2-hour glucose concentrations in additional models. We tested group differences in 44 outcome variables. Many of the lipoprotein measures are highly correlated and thus we also utilized the principal component analysis to reduce the number of outcomes tested (the FACTOR-program in SPSS, version 19, was used). We included the five first components as they explained 95% of the variation and only their eigenvalues were greater than 1.0. We then tested group differences (VLBW versus term) of each individual's Varimax-rotated component scores using adjusted linear regression models. The study was performed according to the declaration of Helsinki. The study protocol was approved by the Ethics Committee at the Helsinki and Uusimaa Hospital District. Written informed consent was obtained from each participant.

Results

VLBW subjects were (Table 1). Using the unadjusted model, there were no differences in the separate 44 fasting lipoprotein measures between VLBW and term (data not shown). Fully adjusted regression models for each measure (Figure 1) showed no group differences in most values. However, compared with controls, VLBW subjects had significantly higher concentration of triglycerides in chylomicrons and largest VLDL particles [XXL-VLDL-TG, difference 0.026 (95% CI: 0.004 to 0.049), P = 0.024] and higher total lipids in these particles [XXL-VLDL-L, difference 0.036 (95% CI 0.005 to 0.037), P = 0.021]. They also had higher triglycerides in small HDL particles [S-HDL-TG, difference 0.026 (95% CI: 0.002 to 0.051), P = 0.037]. No differences in these parameters were observed in the 2-hour OGTT samples (data not shown).
Table 1

Characteristics of the study participants

CharacteristicVLBW ( n = 161)Term (n = 163)P
Women, n (%)
92 (57)
97 (60)
0.8
Men, n (%)
69 (43)
66 (41)
0.8
At birth
 
 
 
Gestational age, mean (SD), wk
29.1 (2.2)
40.1 (1.2)
<0.0001
Birth weight, mean (SD), g
1117 (220)
3575 (471)
<0.0001
Birth weight SDS, mean (SD), SDS
−1.3 (1.5)
0.0 (1.0)
<0.0001
SGA, n (%)
54 (34)
0
 
Parental
 
 
 
Mother’s smoking during pregnancy
30 (19)
25 (15)
0.5
Parental education, n (%)
 
 
0.5
Elementary
17 (11)
11 (7)
 
High school
32 (20)
29 (18)
 
Intermediate
65 (40)
53 (33)
 
University
44 (27)
69 (42)
 
At clinical examination
 
 
 
Age, mean (SD), y
22.4 (2.2)
22.5 (2.2)
0.9
Height, mean (SD), cm
 
 
 
Women
162.1 (7.7)
167.2 (6.8)
<0.0001
Men
174.6 (7.8)
180.4 (6.5)
<0.0001
Body mass index, mean (SD), kg/m2
 
 
 
Women
22.2 (4.0)
22.8 (3.7)
0.3
Men
22.1 (3.7)
23.2 (3.2)
0.06
Daily smoking, n (%)35 (22)54 (33)0.08

VLBW, very low birth weight (≤1500 g).

SGA, small for gestational age (birth weight < −2SD).

Figure 1

Middle: All the 44 lipoprotein subclass measures analysed. Left: A forrestplot of fully adjusted differences in fasting serum samples between VLBW and term subjects. Right: Rotated Component Matrix; using principal component analysis all lipoprotein measures were re-organized into 5 components. Bottom: Factor scores from 5 components that were entered into multiple linear regression models. Vertical line at zero indicates no difference, larger values for VLBW subjects are positive differences. (VLBW, very low birth weight, ≤1500 g; HDL, high-density lipoprotein; LDL, low-density lipoprotein; IDL, intermediate-density lipoprotein; VLDL, very-low-density lipoprotein; TG, triglycerides; C, total cholesterol; L, total lipid; PC, principal component).

Characteristics of the study participants VLBW, very low birth weight (≤1500 g). SGA, small for gestational age (birth weight < −2SD). Middle: All the 44 lipoprotein subclass measures analysed. Left: A forrestplot of fully adjusted differences in fasting serum samples between VLBW and term subjects. Right: Rotated Component Matrix; using principal component analysis all lipoprotein measures were re-organized into 5 components. Bottom: Factor scores from 5 components that were entered into multiple linear regression models. Vertical line at zero indicates no difference, larger values for VLBW subjects are positive differences. (VLBW, very low birth weight, ≤1500 g; HDL, high-density lipoprotein; LDL, low-density lipoprotein; IDL, intermediate-density lipoprotein; VLDL, very-low-density lipoprotein; TG, triglycerides; C, total cholesterol; L, total lipid; PC, principal component). XXL-VLDL-TG and XXL-VLDL-L were somewhat skewed to the right still after the log transformation. Thus, we transformed them with BoxCox formulas and analyzed again the effect of VLBW. In result, the stardardized betas for these two variables changed from log transformed values to boxcox values: XXL-VLDL-TG from 0.13 (p = 0.021) to 0.07 (p = 0.236) and XXL-VLDL-L changed from 0.13 (p = 0.019) to 0.13 (p = 0.20). Adding alcohol as a covariate in the fully adjusted model did not change the observed difference in XXL-VLDL-TG, XXL-VLDL-L, or S-HDL-TG between VLBW subjects and controls. Neither were these differences changed after inclusion of fasting or 2-hour glucose as a covariate in linear regression (Table 2).
Table 2

B and 95% confidence interval (CI) and P for the difference in triglycerides in chylomicrons and extremely large VLDL (XXL-VLDL-TG), in total lipids in these particles (XXL-VLDL-L) as well as in small HDL particles (S-HDL-TG) when adjusted for; 1) full model, 2) + alcohol use, 3) + glucose indices

 
XXL-VLDL-TG
 
XXL-VLDL-L
 
S-HDL-TG
 
 B (95% CI)PB (95% CI)PB (95% CI)P
1
0.026 (0.004, 0.049)
0.024
0.036 (0.005, 0.037)
0.021
0.026 (0.002, 0.051)
0.03
2a
0.030 (0.007, 0.053)
0.001
0.041 (0.011, 0.072)
0.009
0.030 (0.006, 0.057)
0.016
2b
0.028 (0.005, 0.051)
0.016
0.038 (0.008, 0.069)
0.014
0.026 (0.002, 0.051)
0.036
3a
0.024 (0.001, 0.047)
0.040
0.033 (0.002, 0.064)
0.037
0.024 (−0.001, 0.049)
0.059
3b0.022 (0.001, 0.044)0.0440.031 (0.002, 0.061)0.0400.025 (0.001, 0.049)0.045

1) full model; adjustment for age, sex, height, highest parental education, body mass index, mother’s smoking during pregnancy, and daily smoking of the participant.

2a) full model + adjustment for whether the subject ever drinks alcohol (yes or no).

2b) full model + adjustment for whether the subject uses alcohol to get drunk on weekly basis (yes or no).

3a) full model + adjustment for fasting glucose.

3b) full model + adjustment for 2-hour glucose in oral glucose tolerance test.

B and 95% confidence interval (CI) and P for the difference in triglycerides in chylomicrons and extremely large VLDL (XXL-VLDL-TG), in total lipids in these particles (XXL-VLDL-L) as well as in small HDL particles (S-HDL-TG) when adjusted for; 1) full model, 2) + alcohol use, 3) + glucose indices 1) full model; adjustment for age, sex, height, highest parental education, body mass index, mother’s smoking during pregnancy, and daily smoking of the participant. 2a) full model + adjustment for whether the subject ever drinks alcohol (yes or no). 2b) full model + adjustment for whether the subject uses alcohol to get drunk on weekly basis (yes or no). 3a) full model + adjustment for fasting glucose. 3b) full model + adjustment for 2-hour glucose in oral glucose tolerance test. We then performed a principal component analysis, which re-organized all lipoprotein variables into five uncorrelated components. The rotated component loadings for the lipoprotein variables (tabled in Figure 1) characterize principal component 1 (PC1) mainly as a marker of VLDL and triglycerides and PC2 as a marker of LDL, cholesterol and apolipoprotein B (ApoB). In a linear regression model, scores for PC1 were higher in VLBW subjects than in control subjects [standardized difference 0.12 (95% CI: 0.00 to 0.23), P = 0.049] (Figure 1). Principal component analysis for 2-hour OGTT samples yielded similarly to five components. Regarding these components, VLBW and control subjects scored similarly (P-values ≥ 0.47).

Discussion

We observed that, in comparison to controls, adults born at VLBW have higher concentrations of triglycerides both in the largest VLDL particles and in small HDL particles. These potentially atherogenic characteristics of the lipid profile [21] may contribute to an increased risk of cardiovascular disease in adults born preterm at VLBW. In the general population a weak negative correlation has been reported between birth weight and serum total cholesterol [22]. Similarly, an inverse correlation has been reported between gestational age and serum triglycerides in 11-15-year-olds [8], total cholesterol in 44-45-year-old women [9], and LDL cholesterol and ApoB among 16-year-old boys [10]. Based on previous studies on preterm-born subjects, conventionally measured lipid levels in fasting blood samples are, however, similar as in term-born individuals [2,5,7,11-13]. For instance, in the current cohort the levels of total, and HDL cholesterol, as well as serum triglycerides do not differ between the VLBW subjects and controls [5]. However, triglycerides in the largest VLDL and small HDL particles are higher in the VLBW than in the term-born participants. These new extensive lipoprotein data thus suggest particular impairments in triglyceride metabolism in relation to VLBW. As triglyceride-mediated pathways are causally related to coronary heart disease [23] these findings may partly explain the increased risk for cardiovascular diseases among the VLBW individuals in adulthood and also lend support for further studies with more detailed lipoprotein measures [14,15]. A strength of this study is the measurement of extensive lipoprotein subclass data at both in the fasting state and 2-hours after an oral glucose challenge. We were also able to adjust for most potential confounding factors, such as body mass index, smoking, and parental education. These factors did not explain the observed difference between VLBW and control subjects. A common challenge, as also here, in the studies of VLBW individuals is the relatively small number of study participants available. Combined with the rather high number of lipoprotein measures analysed, this created a statistically difficult situation; however, the trends for biologically related variables supported the findings as well as reduction of the outcome variables using principal component analysis. The remaining skewedness in the log-transformed variables may, in general, cause false negative findings. During the primary analysis, we further ‘Box-Cox transformed’ the variables when it was suspected logarithmic transformation did not adequately remove the skewedness. After this further transformation the difference estimates did not increase, but decreased, approximately by 50% at maximum. Thus, these two methods, together with the principal component approach, support VLBW adults exhibit a difference in the extremely large VLBW triglycerides and total lipids. In conclusion, we found atherogenic characteristics in the lipoprotein profile of young adults born preterm at VLBW. The differences between the VLBW and the term-born individuals were not detectable with conventional lipid measurements. These findings, though subtle, may indicate that impaired triglyceride metabolism partly contributes to the increased risk for cardiovascular disease among adults born severely preterm.

Abbreviations

ApoA1: Apolipoprotein A-I; ApoB: Apolipoprotein B; C: Total cholesterol; D: Diameter; HDL: High-density lipoprotein; IDL: Intermediate-density lipoprotein; LDL: Low-density lipoprotein; L: Total lipids; NMR: Nuclear magnetic resonance; OGTT: Oral glucose tolerance test; PC: Principal component; SGA: Small for gestational age; TG: Triglycerides; VLBW: Very low birth weight; VLDL: Very-low-density lipoprotein.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KW took part in carrying out the statistical analyses, participated in planning of the study, and drafted the manuscript. PH took part in carrying out the statistical analyses, and participated in writing the manuscript. PH, EK, SA, A-LJ, and JGE participated in the design of the clinical study. PH, EK, SA, and A-LJ collected the study participants and PH, EK, SA, and JGE performed the clinical studies. PS, AK, and MA-K designed and performed the NMR analyses. MA-K participated in the statistical interpretations as well as in writing the manuscript. All authors read and approved the final manuscript.
  22 in total

1.  Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker; Yadong Cui
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

2.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism.

Authors:  Pasi Soininen; Antti J Kangas; Peter Würtz; Taru Tukiainen; Tuulia Tynkkynen; Reino Laatikainen; Marjo-Riitta Järvelin; Mika Kähönen; Terho Lehtimäki; Jorma Viikari; Olli T Raitakari; Markku J Savolainen; Mika Ala-Korpela
Journal:  Analyst       Date:  2009-07-30       Impact factor: 4.616

3.  Ambulatory blood pressure in young adults with very low birth weight.

Authors:  Petteri Hovi; Sture Andersson; Katri Räikkönen; Sonja Strang-Karlsson; Anna-Liisa Järvenpää; Johan G Eriksson; Anu-Katriina Pesonen; Kati Heinonen; Riikka Pyhälä; Eero Kajantie
Journal:  J Pediatr       Date:  2010-01       Impact factor: 4.406

4.  Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

Authors:  Michael H Davidson; Christie M Ballantyne; Terry A Jacobson; Vera A Bittner; Lynne T Braun; Alan S Brown; W Virgil Brown; William C Cromwell; Ronald B Goldberg; James M McKenney; Alan T Remaley; Allan D Sniderman; Peter P Toth; Sotirios Tsimikas; Paul E Ziajka; Kevin C Maki; Mary R Dicklin
Journal:  J Clin Lipidol       Date:  2011 Sep-Oct       Impact factor: 4.766

5.  Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci.

Authors:  Taru Tukiainen; Johannes Kettunen; Antti J Kangas; Leo-Pekka Lyytikäinen; Pasi Soininen; Antti-Pekka Sarin; Emmi Tikkanen; Paul F O'Reilly; Markku J Savolainen; Kimmo Kaski; Anneli Pouta; Antti Jula; Terho Lehtimäki; Mika Kähönen; Jorma Viikari; Marja-Riitta Taskinen; Matti Jauhiainen; Johan G Eriksson; Olli Raitakari; Veikko Salomaa; Marjo-Riitta Järvelin; Markus Perola; Aarno Palotie; Mika Ala-Korpela; Samuli Ripatti
Journal:  Hum Mol Genet       Date:  2011-12-09       Impact factor: 6.150

6.  Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.

Authors:  Nadeem Sarwar; Manjinder S Sandhu; Sally L Ricketts; Adam S Butterworth; Emanuele Di Angelantonio; S Matthijs Boekholdt; Willem Ouwehand; Hugh Watkins; Nilesh J Samani; Danish Saleheen; Debbie Lawlor; Muredach P Reilly; Aroon D Hingorani; Philippa J Talmud; John Danesh
Journal:  Lancet       Date:  2010-05-08       Impact factor: 79.321

7.  Abnormal lipid profile and hyperinsulinaemia after a mixed meal: additional cardiovascular risk factors in young adults born preterm.

Authors:  J Rotteveel; M M van Weissenbruch; J W R Twisk; H A Delemarre-Van de Waal
Journal:  Diabetologia       Date:  2008-05-22       Impact factor: 10.122

8.  Gestational age and risk factors for cardiovascular disease: evidence from the 1958 British birth cohort followed to mid-life.

Authors:  Rachel Cooper; Kate Atherton; Chris Power
Journal:  Int J Epidemiol       Date:  2008-07-25       Impact factor: 7.196

9.  Effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic Finnish men.

Authors:  Alena Stančáková; Jussi Paananen; Pasi Soininen; Antti J Kangas; Lori L Bonnycastle; Mario A Morken; Francis S Collins; Anne U Jackson; Michael L Boehnke; Johanna Kuusisto; Mika Ala-Korpela; Markku Laakso
Journal:  Diabetes       Date:  2011-03-18       Impact factor: 9.461

10.  Metabonomic, transcriptomic, and genomic variation of a population cohort.

Authors:  Michael Inouye; Johannes Kettunen; Pasi Soininen; Kaisa Silander; Samuli Ripatti; Linda S Kumpula; Eija Hämäläinen; Pekka Jousilahti; Antti J Kangas; Satu Männistö; Markku J Savolainen; Antti Jula; Jaana Leiviskä; Aarno Palotie; Veikko Salomaa; Markus Perola; Mika Ala-Korpela; Leena Peltonen
Journal:  Mol Syst Biol       Date:  2010-12-21       Impact factor: 13.068

View more
  6 in total

Review 1.  Preterm birth and mortality in adulthood: a systematic review.

Authors:  Casey Crump
Journal:  J Perinatol       Date:  2019-11-25       Impact factor: 2.521

2.  Increased circulating endothelial progenitor cells (EPCs) in prepubertal children born prematurely: a possible link between prematurity and cardiovascular risk.

Authors:  Panagiota Markopoulou; Eleni Papanikolaou; Sofia Loukopoulou; Paraskevi Galina; Aimilia Mantzou; Tania Siahanidou
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

3.  Metabolic signatures of birthweight in 18 288 adolescents and adults.

Authors:  Peter Würtz; Qin Wang; Marjo Niironen; Tuulia Tynkkynen; Mika Tiainen; Fotios Drenos; Antti J Kangas; Pasi Soininen; Michael R Skilton; Kauko Heikkilä; Anneli Pouta; Mika Kähönen; Terho Lehtimäki; Richard J Rose; Eero Kajantie; Markus Perola; Jaakko Kaprio; Johan G Eriksson; Olli T Raitakari; Debbie A Lawlor; George Davey Smith; Marjo-Riitta Järvelin; Mika Ala-Korpela; Kirsi Auro
Journal:  Int J Epidemiol       Date:  2016-10       Impact factor: 7.196

4.  Diurnal Cortisol Patterns and Dexamethasone Suppression Test Responses in Healthy Young Adults Born Preterm at Very Low Birth Weight.

Authors:  Nina Kaseva; Riikka Pyhälä; Anu-Katriina Pesonen; Katri Räikkönen; Anna-Liisa Järvenpää; Sture Andersson; Johan G Eriksson; Petteri Hovi; Eero Kajantie
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

5.  Association of preterm birth with lipid disorders in early adulthood:  A Swedish cohort study.

Authors:  Casey Crump; Jan Sundquist; Kristina Sundquist
Journal:  PLoS Med       Date:  2019-10-18       Impact factor: 11.069

6.  Fine particulate matter exposure and lipid levels among children in Mexico city.

Authors:  Laura A McGuinn; Brent A Coull; Itai Kloog; Allan C Just; Marcela Tamayo-Ortiz; Citlalli Osorio-Yáñez; Andrea A Baccarelli; Rosalind J Wright; Martha M Téllez-Rojo; Robert O Wright
Journal:  Environ Epidemiol       Date:  2020-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.